項目 | 內容 |
---|---|
時間 | 2020-08-30的12:30至15:30 |
類型 | 甲類 |
積分 | 3 |
主辦單位 | 台灣安進藥品有限公司 、中華民國血液病學會 |
會議地點 | 視訊(不限額)+現場視訊(限額20人,需事先登記) |
多發性骨髓瘤教育研討會
109年8月30日(日)12:30:00
安進公司邀請本會於8/30(日)12:30-15:30合辦「多發性骨髓瘤教育研討會」,此場會議會做hybrid (現場視訊+視訊)。
(1)現場視訊(會議地點:台北;已另e-mail通知會員):限額20人,請會員填下面表單,透過網路報名,恕不受理e-mail或電話或傳真報名。將以網路報名先後順序,錄取前20位報名者,額滿即截止報名,欲報從速。
(2)視訊:不限額,請另至官網報名,註冊網址: https://onemediachannel.com/event/register/AMGENMETA2020 。註冊後會收到Email通知,內有會議連結,於線上研討會開始時點擊即可進入會議室。
[註]參加現場視訊會議,有事先報名及到場親自簽到者,可獲教育學分(血液病學會甲類3分、癌症醫學會A類2分、骨髓移植學會1.5分);僅透過視訊參與者,無法累積教育學分,請見諒!
Co-chairs:Meletios Dimopoulos (Greece); Jeffrey Huang (Taiwan)
Regional Faculty:
Hang Quach (Australia)
Steering Committee Faculty:Wee Joo Chng (Singapore); Suporn Chuncharunee (Thailand); Simon Harrison (Australia);
Jeffrey Huang (Taiwan);Jin-Seok Kim (South Korea)
(1)現場視訊(會議地點:台北;已另e-mail通知會員):限額20人,請會員填下面表單,透過網路報名,恕不受理e-mail或電話或傳真報名。將以網路報名先後順序,錄取前20位報名者,額滿即截止報名,欲報從速。
(2)視訊:不限額,請另至官網報名,註冊網址: https://onemediachannel.com/event/register/AMGENMETA2020 。註冊後會收到Email通知,內有會議連結,於線上研討會開始時點擊即可進入會議室。
[註]參加現場視訊會議,有事先報名及到場親自簽到者,可獲教育學分(血液病學會甲類3分、癌症醫學會A類2分、骨髓移植學會1.5分);僅透過視訊參與者,無法累積教育學分,請見諒!
Co-chairs:Meletios Dimopoulos (Greece); Jeffrey Huang (Taiwan)
Regional Faculty:
Hang Quach (Australia)
Steering Committee Faculty:Wee Joo Chng (Singapore); Suporn Chuncharunee (Thailand); Simon Harrison (Australia);
Jeffrey Huang (Taiwan);Jin-Seok Kim (South Korea)
Time | Session | Faculty |
---|---|---|
12:30-12:35 | Opening and Welcome | Co-chairs: Jeffrey Huang (Taiwan) Meletios Dimopoulos (Greece) |
Focus on Early Multiple Myeloma | ||
12:35-12:50 | Identifying Patients at Risk | Meletios Dimopoulos (Greece) |
12:50-13:05 | Initial Treatment for NDMM | Hang Quach (Australia) |
Assessing Treatment Options to Best Meet Your RRMM Patient’s Needs | ||
13:05-13:40 | How I Treat RRMM Myeloma Patients Followed by Q&A session |
Wee Joo Chng (Singapore) Meletios Dimopoulos (Greece) |
13:40-14:00 | Novel Therapies: What Could be the Impact? Followed by Q&A Session |
Simon Harrison (Australia) |
14:00-14:10 | Refreshment Break | All Faculty |
COVID-19 and Multiple Myeloma Treatment | ||
14:10-14:20 | Advice from HemeOnc Professional Bodies for Managing Multiple Myeloma Patients | Wee Joo Chng (Singapore) |
14:20-14:30 | Q&A Session | All Faculty |
Concomitant Treatment and Adverse Events Management | ||
14:30-14:50 | Therapeutic Strategies for Treating Bone Disease Followed by Q&A Session |
Jeffrey Huang (Taiwan) |
14:50-15:35 | Awareness of Treatment Emergent Adverse Events and Underlying Comorbidities in RRMM 3 x Patient Cases |
Wee Joo Chng (Singapore) Jin-Seok Kim (South Korea) Suporn Chuncharunee (Thailand) |
15:35-15:45 | Meeting Summary and Close | Jeffrey Huang (Taiwan) |